Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

DBV Technologies reported $0 in Debt for its fiscal quarter ending in June of 2022.

Debt Change Date
Acadia Pharmaceuticals USD 0 0 Jun/2022
Alnylam Pharmaceuticals USD 1.02B 966K Sep/2023
Amarin USD 0 0 Jun/2022
BioCryst Pharmaceuticals USD 833.18M 13.88M Sep/2023
BioMarin Pharmaceutical USD 1.09B 990K Sep/2023
DBV Technologies USD 0 0 Jun/2022
Esperion Therapeutics USD 261.16M 427K Sep/2023
Galectin Therapeutics USD 61.14M 781K Sep/2023
Halozyme Therapeutics USD 1.5B 1.62M Sep/2023
Incyte USD 31.92M 734K Sep/2023
Insmed USD 1.18B 7.14M Sep/2023
Ionis Pharmaceuticals USD 1.29B 34.92M Sep/2023
Neurocrine Biosciences USD 169.9M 200K Sep/2023
PTC Therapeutics USD 1.36B 2.35M Sep/2023
Sarepta Therapeutics USD 1.24B 1.24M Sep/2023
Ultragenyx Pharmaceutical USD 0 0 Jun/2022
United Therapeutics USD 800M 0 Sep/2023